Der DOW JONES gewinnt heute 100,85 Zähler oder 1,19% auf 8574,26 Punkte
Die Hightechs des Nasdaq Composite gewinnen 23,34 Zähler oder 1,71% auf 1367,09 Punkte.
Meistgehandelte Aktie
Der NASDAQ 100 gewinnt 18,01 Zähler oder 1,77% auf 1032,85Punkte
besser zeigte sich der Amex Interactiv Internet Index (IIX) , er gewinnt aktuell 2,53 Zähler bzw 3 Prozent auf 86,25 Punkte .
Der PHLX Semiconductor Sector (SOX) gewinnt 15,40 Zähler oder 5% auf 323,02 Punkte
Der Amex Biotech Index (BTK) verliert 1,42 Zähler bzw. 0,40% auf 349,85Punkte
Der S&P 500 (SPX) gewinnt 12,41 Zähler oder 1,4% auf 904,41Punkte
***
EU/$ >> 1,008 ***
AFTER THE CLOSE
Digitas updates Q4 guidance (DTAS) 3.42 +0.37: Now anticipates Q4 fee revenue for the fourth quarter of $50 million-$52 million, as compared with $48 million-$50 million in fee revenue forecasted in the company's earnings announcement for the third quarter; also expects pro forma cash earnings of $0.05--$0.07 per share for the fourth quarter of 2002 "compared to $0.03--$0.05 as previously announced."
Pegasus Solutions updates full year guidance (PEGS) 10.03 -0.12: Co expects modest full year growth with revenue ranging from $175 million to $185 million and cash earnings ranging from $0.55 to $0.62 per diluted share -- Multex consensus estimates are $0.53 per share and $175.9 billion respectively.
Xilinx says Dec qtr revs to be up 1-3% sequentially (XLNX) 21.48 +0.90: Announces that their Dec qtr revenues are expected to be up 1-3% sequentially (about $280.6-$286.2 mln) vs previous guidance range of $278-$285 mln. Expects North American and European revenues to be flattish sequentially, and Japan and Asia revenues to be up sequentially; expects days sales outstanding and days of inventory at both distributors and XLNX to trend lower sequentially.
Photronics tops estimates (PLAB) 13.39 +0.46: Reports Q4 (Oct) loss of $0.06 per share,
$0.03 better than the Multex consensus of ($0.09); revenues fell 4% year/year to $90.1 mln vs the $90.3 mln consensus.
New York Times reaffirms Y02, gives Y03 guidance (NYT) 46.33 +0.63: Sees EPS in the middle of previously issued $1.90-2.00 range, Y03 EPS growth rate to range from "mid-single digits to low-double digits". Based on Y02 EPS of $1.95, this equates to Y03 EPS of approximately $2.05-2.19 vs Multex consensus of $2.23.
Cymer updates Q4 guidance (CYMI) 33.55 +2.06: Expects that total revenue in the fourth quarter of 2002 will be "at the more favorable end" of the previously anticipated 20 to 25 percent decline from the $84.4 mln in revenue posted in the third quarter of this year; still expects book-to-bill ratio for the quarter to come in "at or above 1.0."
Medtronic updates Q3 and Q4 guidance -- Dow Jones (MDT) 46.12 -0.13: Company sees Q3 (Jan) earnings of $0.35 per share and Q4 earnings of $0.40 per share -- Multex consensus estimates are for Q3 earnings of $0.35 per share and Q4 earnings of $0.40 per share respectively.
----------------------------------
Nachbörsliche WINNER+LOSER:
Regulärer Handel +After Hours- Top 100
____________________________________________
Nasdaq 100 Future
Nasdaq 100 After Hours Indicator

_____________________________________________
_____________________________________________
KURSLISTE in €
DAX ------------------------------
NEMAX 50

DOW JONES 30 ------------
NASDAQ 100
US-STOCKS -------------------
MDAX

--------------------------------------------------------------
NACHBÖRSLICHE QUARTALSBERICHTE
EARNINGS KALENDER
WIRTSCHAFTSDATEN -VORSCHAU
FED- KALENDER
UP- and DOWNGRADES